课题基金 / 基金详情

ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS

ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
ACTG377--蛋白酶抑制剂组合的抗逆转录病毒治疗方案
批准号:
6264761
负责人:
Stuart E Starr
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Stuart E Starr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ACTG 377 is a Phase I/II, randomized, open label, multi-arm study with experimental therapies added in a rolling protocol format. The primary goal of ACTG 377 is to evaluate a series of combinations of antiretroviral agents with respect to the change in plasma HIV-1 RNA copy number, safety and tolerance, and to determine which of these therapies warrants investigation in a Phase III study. This study evaluates d4T/Nevirapine/ Ritonavir vs. d4T/3TC/Nelfinavir vs. d4T/Nevirapine/Nelfinavir vs. d4T/3TC/Nevirapine/Nelfinavir with respect to their ability to induce undetectable plasma HIV-1 RNA copy number and to reduce plasma HIV-1 RNA copy number by > 2 logs at 12 weeks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6595455
  • 项目类别:
  • 资助金额:
    $18.67万
  • 财政年份:
    2002
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6306322
  • 项目类别:
  • 资助金额:
    $0.06万
  • 财政年份:
    1999
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG185--USE OF HIVIG FOR PREVENTION OF MATERNAL/FETAL TRANSMISSION OF HIV
  • 批准号:
    6116874
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG 265--LIVE ATTENTUATED VARICELLA VACCINE IN HIV INFECTION CHILDREN
  • 批准号:
    6116899
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位:
海外基金